Research graph
References from Distinct Longitudinal Antibody Responses Following Primary Influenza Infection or Vaccination in Infants: A Prospective Birth Cohort Study. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/j.vaccine.2011.04.048
10.1016/j.vaccine.2011.04.048 · External reference
10.1016/j.celrep.2022.110337
10.1016/j.celrep.2022.110337 · External reference
Age-specific differences in the dynamics of protective immunity to influenza
10.1038/s41467-019-09652-6 · 2019 · External reference
On the doctrine of original antigenic sin
1960 · External reference
Original antigenic sin: how first exposure shapes lifelong anti–influenza virus immune responses
10.4049/jimmunol.1801149 · 2019 · External reference
10.1128/jvi.00169-00119
10.1128/jvi.00169-00119 · External reference
10.1371/journal.ppat.1008109
10.1371/journal.ppat.1008109 · External reference
10.1111/imr.12900
10.1111/imr.12900 · External reference
Immune imprinting in early life shapes cross-reactivity to influenza B virus haemagglutinin
10.1038/s41564-024-01732-8 · 2024 · External reference
Imprinting and editing of the human CD4 T cell response to influenza virus
10.3389/fimmu.2019.00932 · 2019 · External reference
The effects of imprinting and repeated seasonal influenza vaccination on adaptive immunity after influenza vaccination
10.3390/vaccines8040663 · 2020 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1016/j.ymeth.2019.01.005
10.1016/j.ymeth.2019.01.005 · External reference
10.1111/cei.13234
10.1111/cei.13234 · External reference
Transplacental transfer efficiency of maternal antibodies against influenza A (H1N1) pdm09 virus and dynamics of naturally acquired antibodies in Chinese children: a longitudinal, paired mother–neonate cohort study
10.1016/s2666-5247(23)00181-7 · 2023 · External reference
Influenza imprinting in childhood and the influence on vaccine response later in life
2019 · External reference
10.1126/scitranslmed.3006637
10.1126/scitranslmed.3006637 · External reference
Imprinted anti-hemagglutinin and anti-neuraminidase antibody responses after childhood infections of A (H1N1) and A (H1N1) pdm09 influenza viruses
2023 · External reference
10.1371/journal.ppat.1010317
10.1371/journal.ppat.1010317 · External reference
Immune imprinting: The persisting influence of the first antigenic encounter with rapidly evolving viruses
10.1080/21645515.2024.2384192 · 2024 · External reference
10.1101/2023.04.10.23288360
10.1101/2023.04.10.23288360 · External reference
10.1016/j.cell.2023.08.044
10.1016/j.cell.2023.08.044 · External reference
Infant antibody repertoires during the first two years of influenza vaccination
2022 · External reference
10.1101/cshperspect.a038471
10.1101/cshperspect.a038471 · External reference
With a little help from T follicular helper friends: humoral immunity to influenza vaccination
10.4049/jimmunol.1800986 · 2019 · External reference
10.3390/pathogens8040167
10.3390/pathogens8040167 · External reference
10.1016/j.vaccine.2004.02.030
10.1016/j.vaccine.2004.02.030 · External reference
Challenges for the newborn following influenza virus infection and prospects for an effective vaccine
10.3389/fimmu.2020.568651 · 2020 · External reference
10.1007/82_2014_425
10.1007/82_2014_425 · External reference
Unresolved reference
External reference
10.1126/science.aaz8432
10.1126/science.aaz8432 · External reference
Understanding antibody responses in early life: baby steps towards developing an effective influenza vaccine
10.3390/v13071392 · 2021 · External reference
Antibody function predicts viral control in newborn monkeys immunised with an influenza virus HA stem nanoparticle
10.1038/s41467-025-59149-8 · 2025 · External reference
Duration of infant protection against influenza illness conferred by maternal immunization: secondary analysis of a randomized clinical trial
10.1001/jamapediatrics.2016.0921 · 2016 · External reference
Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination
10.1016/j.vaccine.2008.03.016 · 2008 · External reference
10.1128/jvi.77.15.8418-8425.2003
10.1128/jvi.77.15.8418-8425.2003 · External reference
10.1371/journal.ppat.1008411
10.1371/journal.ppat.1008411 · External reference
10.1371/journal.ppat.1009527
10.1371/journal.ppat.1009527 · External reference
10.1016/j.xcrm.2022.100509
10.1016/j.xcrm.2022.100509 · External reference
10.1126/sciadv.add2032
10.1126/sciadv.add2032 · External reference
10.1128/jvi.02424-08
10.1128/jvi.02424-08 · External reference
10.1128/cvi.00613-15
10.1128/cvi.00613-15 · External reference
Middle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibility
10.1038/s41467-020-18465-x · 2020 · External reference
Development of a nucleoside-modified mRNA vaccine against clade 2.3. 4.4 b H5 highly pathogenic avian influenza virus
10.1038/s41467-024-48555-z · 2024 · External reference
10.1038/s41586-021-04356-8
10.1038/s41586-021-04356-8 · External reference
